Follow Us :

Global Bioanalytical Testing Market, By Test Type (ADME, Pharmacokinetic Test, pharmacodynamics’ Test, Bioequivalence Test, Bioavailability Test and Other), By Molecule Type (Small Molecule and Large Molecule), By Type (Cell-Based Assays, Virology Testing, Method Development Optimization And Validation; Serology, Immunogenicity, And Neutralizing Antibodies, Biomarker Testing, Pharmacokinetic Testing, and Others), By Application (Oncology, Neurology, Infectious Diseases, Gastroenterology, Cardiology and Other), By End User (Pharmaceutical and Biopharmaceutical Companies, Contract Development and Manufacturing Organizations and Contract Research Organizations), By Geography {North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa} – Industry Trends and Forecast to 2028

Report ID: HC0921BT | Published Date: Sept-2021 | Category: Healthcare | Base Year: 2023 | Format: Report Formats

The bioanalytical Testing market is expected to reach USD 6.5 Billion by 2028 exhibiting a CAGR of 9.4% from 2021 to 2028. Phoenix Research Study on the bioanalytical testing market provides insight and analysis regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market’s growth.

Bioanalytical Testing Market: Insight and Analysis
The quantitative evaluation of xenobiotics and biological compounds, such as small molecule medications and their metabolites, is known as bioanalysis. Bioanalytical testing services are utilized in the development and validation of robust bioanalytical processes in body fluids and tissue specimens. From Phase I to Phase IV, these assays are used to aid pre-clinical and clinical research. Furthermore, the development of biosimilar and combination drugs, as well as other new medicines, has increased demand for certain types of tests such as electrochemical, electrophoresis titrimetric assays, and immunoassays.

Global Bioanalytical Testing Market

The demand for Bioanalytical Testing is gaining enormous prominence and promising exponential growth. Due to the need for bioanalytical testing, it is skyrocketing. Major pharmaceutical companies are increasingly outsourcing R&D efforts to focus on their core competencies, and increased efficiency is expected to boost bioanalytical testing’s market penetration. Furthermore, increased government financing or initiatives to combat infectious illness outbreaks, such as Coronavirus Disease, would help to enhance the industry.

This Bioanalytical Testing report discusses the market potential and trends, opportunities, untapped and emerging revenue pockets, year-on-year growth analysis, market revenue, application and user behavior, competitor analysis, local and major player impact and heat mapping, landscape, recent strategic activities, trade data, import-export data, supply and demand analysis, production and value chain brand share, company market share and ranking analysis, the impact of covid 19 and regulatory changes, technology roadmap, application niches, and so on.

Phoenix research consultants use their proprietary research methodology to evaluate data that involves data mining, analysis of the impact of data variables on the market, and primary validation. Furthermore, other data models consist of a market overview and guide, company matrix, key intensity vendor mapping, market forecasting analysis, company share analysis, top-down and bottom-up analysis, and others.

Bioanalytical Testing Market – Pre and Post-Covid Analysis
The coronavirus disease (COVID-19) pandemic outbreak has created extreme uncertainty in the market growth globally. The pandemic outbreak has affected and changed the complete dynamics of the bioanalytical testing market in ways that are hard to believe. The efficacy and intensity of containment efforts to the extent of supply disruptions, shifts in spending patterns, behavioral changes (such as avoiding purchasing), the repercussions of the dramatic tightening in global market conditions, confidence effects, volatile commodity prices, and increasing debt burdens. Due to COVID-19, all the countries have faced a multi-layered crisis comprising domestic economic disruptions, plummeting external demand, collapse in the prices, and collapse in supply and demand of the products across the globe.

According to the United Nations, in 2020, the global economy could shrink by almost 1% due to the impact of the COVID-19 pandemic. The COVID-19 pandemic outbreak has created extreme uncertainty in the Bioanalytical Testing market growth around the globe. The COVID-19 outbreak from December 2019 has impacted more than 100 countries across the globe and significantly it has mainly impacted the Bioanalytical Testing market in 2020. The pandemic has affected the overall medical device in various ways as the demand for some of the products/services has increased, but due to supply chain market disruption, manufacturing was not able to fulfill the order resulting in a financial impact on the vendors.

Contact for more details on Pre and Post Covid 19 impact on supply and demand, price, manufacturer/provider, End-use industry among other

Bioanalytical Testing Market: Study Scope and Market Engineering
The global market entitled “bioanalytical testing” has been segmented into test type, molecule type, type, application, end-user, and region. Based on the test type, the market is segmented into ADME, pharmacokinetic test, pharmacodynamics test, bioequivalence test, bioavailability test, and others.
• Based on molecule type market is segmented into small molecule and large molecule.
• Based on the type, the market is segmented into cell-based assays, virology testing, method development optimization and validation; serology, immunogenicity, and neutralizing antibodies, biomarker testing, pharmacokinetic testing, and others.
• Based on the application, the market is segmented into oncology, neurology, infectious diseases, gastroenterology, cardiology, and others.
• Based on the end user, the market is segmented into pharmaceutical and biopharmaceutical companies, contract development and manufacturing organizations, and contract research organizations.

Bioanalytical Testing Market: Geographical Coverage and Analysis
The countries covered in the bioanalytical testing market report are U.S. and Canada in North America, Brazil, Mexico, Columbia, and the Rest of South America as part of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Rest of Europe in Europe, Japan, China, India, South Korea, Australia, Singapore and Rest of Asia-Pacific in the Asia-Pacific, GCC countries, South Africa, Rest of Middle East and Africa as a part of Middle East and Africa.

North America holds the largest market share in global bioanalytical testing followed by Europe and the Asia Pacific region. Due to rising technological advancements and government funding R&D in the pharmaceutical industry in the region, the United States dominates the North American market. In addition, the region has a well-established healthcare infrastructure, which allows for the quicker deployment of new technology.

Individual market-affecting factors and changes in regulation in the domestic market are also discussed in the report, which has an impact on the market’s current and future developments. Top-down and bottom-up value chain analysis, trends, Macro and Microeconomic indicators, Pestle and Porter’s five forces tools, and case studies are only a few data sources used to anticipate the market scenario for different countries. Additionally, while offering forecast analysis of the country data, the presence and availability of global brands, as well as the obstacles they face owing to significant or scarce competition from local and domestic brands, the influence of domestic tariffs, and trade routes are all taken into account.

Bioanalytical Testing Market: Competitive Insights
The global bioanalytical testing market is highly competitive, and major players have used various approaches to raise their footprints in this market such as new product advancements, acquisitions, contracts, joint ventures, alliances, acquisitions, and others. The scope of the study includes Bioanalytical Testing market revenue for Global, Asia-Pacific, North America, Europe, South America, and the Middle East & Africa. Company overview, financials, revenue analysis, market potential, research and development, strategic initiatives, company footprint, strengths and weaknesses, product launch, product width and breadth, and application dominance are all included in the details. The data points presented above are solely related to the companies’ focus on the Bioanalytical Testing markets for the retail industry.

The major players covered in the bioanalytical testing market report are Charles River Laboratories., Medpace and WuXi AppTec, Eurofins Scientific, IQVIA, SGS SA, Covance Inc., Intertek Group plc, Pharmaceutical Research Associates Inc., Syneos Health., ICON plc, Frontage Labs., PPD Inc., Parexel International Corporation., Almac Group, Celerion, Altasciences., BioAgilytix Labs., LGC Limited among other domestic and global players. Market share data is available for global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA), and South America separately. Pheonix research understands competitive strengths and provides competitive analysis for each competitor separately.

Bioanalytical Testing Market Segmentation:
By Test Type
• Pharmacokinetic Test
• Pharmacodynamics Test
• Bioequivalence Test
• Bioavailability Test
• Other

By Molecule Type
• Small Molecule
• Large Molecule

By Type
• Cell-Based Assays
• Virology Testing
• Method Development Optimization Validation
• Serology
• Immunogenicity
• Neutralizing Antibodies
• Biomarker Testing
• Pharmacokinetic Testing
• Others

By Application
• Oncology
• Neurology
• Infectious Diseases
• Gastroenterology
• Cardiology

By Geography
• North America
o U.S.
o Canada

• Europe
o Germany
o Italy
o U.K.
o France
o Spain
o Netherlands
o Belgium
o Switzerland
o Russia
o Poland
o Turkey
o Rest Europe

• Asia-Pacific
o Japan
o China
o India
o South Korea
o Taiwan
o Rest of Asia-Pacific

• South America
o Mexico
o Brazil
o Argentina
o Rest of Latin America

• Middle East and Africa
o GCC Countries
o South Africa
o North Africa
o Egypt
o Rest of Middle East and Africa

Request TOC
Please request TOC of this report from here
Please enable JavaScript in your browser to complete this form.

      Licence Options